
Resistance Training Appears to Restore Physical Strength, Immune Health in Frail or At-Risk Cancer Survivors
Key Takeaways
- Enrollment included eight long-term cancer survivors with frailty features and eight caregiver controls, enabling comparison of inflammatory markers, immune function metrics, and stool microbiome composition at baseline.
- Pretreatment sequelae manifested as systemic inflammation, lower immune function, and altered gut biomes in survivors, consistent with chemotherapy- and radiation-associated accelerated immunologic and musculoskeletal aging.
A 10-week resistance program boosted cancer survivors’ strength, immune function, and gut microbiome.
Cancer survivors significantly improved their strength and immune health after completing a 10-week resistance training program as part of a pilot study led by
“This study shows that a structured strength-training program may help cancer survivors regain strength and improve their immune health after treatment,” says Dr. Holtan.
The study enrolled eight long-term cancer survivors classified as either frail or at risk of becoming frail — exhibiting low energy or self-reporting that they were exhausted — plus eight caregivers who served as healthy controls. From research blood and stool samples taken at the start of the study, the cancer survivors were found to have evidence of inflammation, lower immune function and
All participants then completed a median of 25 personalized resistance training sessions. Follow-up research tests at the end of the program revealed that the differences in blood and gut biomes were no longer distinguishable between patients and their healthy counterparts. Dr. Holtan and her research team hypothesize that strength training may do more for cancer survivors than just adding muscle mass.
“The pilot study results are encouraging, and they raise an intriguing question: Could muscle itself help protect against cancer recurrence and other treatment complications?” notes Dr. Holtan.
Dr. Holtan’s co-investigators included collaborators from Oregon Health & Science University, the University of Minnesota and Brook Army Medical Center at Fort Sam Houston.






































































